Company · CIK 0001357459 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
PALISADE BIO, INC. · PALI
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2026 GForm 4 → | Aug 21, 6:26 pm EDT | John David FinleyCEO, CFO, Director | 176,800 | — | — | 88,451 | — | |
| Jul 8, 2026 PForm 4 → | Jul 10, 6:14 pm EDT | Robert Baltera Jr.Director | 45,000 | $1.97 | $88,698 | 461,904 | +10.8% | |
| Jul 7, 2026 SForm 4 → | Jul 8, 6:52 pm EDT | Mitchell Lawrence JonesChief Medical Officer | 51,880 | $2.05 | $106,536 | 94,009 | −35.6% | |
| Jul 7, 2026 SForm 4 → | Jul 8, 6:49 pm EDT | John David FinleyCEO, CFO, Director | 146,798 | $2.07 | $303,343 | 217,555 | −40.3% | |
| Jul 6, 2026 PForm 4 → | Jul 8, 6:56 pm EDT | Robert Baltera Jr.Director | 50,000 | $2.04 | $102,084 | 416,904 | +13.6% | |
| Jul 6, 2026 MForm 4 → | Jul 8, 6:52 pm EDT | Mitchell Lawrence JonesChief Medical Officer | 131,167 | — | — | 145,889 | — | |
| Jul 6, 2026 MForm 4 → | Jul 8, 6:49 pm EDT | John David FinleyCEO, CFO, Director | 335,300 | $0.70 | $93 | 217,688 | — | |
| Jul 1, 2026 PForm 4 → | Jul 6, 7:48 pm EDT | Robert Baltera Jr.Director | 30,000 | $1.98 | $59,400 | 366,904 | +8.90% | |
| Jun 10, 2026 AForm 4 → | Jun 18, 4:10 pm EDT | Robert Baltera Jr.Director | 336,904 | — | — | 336,904 | — | late |
| Jun 10, 2026 AMForm 4 → | Jun 12, 8:14 pm EDT | Binxian WeiDirector | 612,500 | — | — | 613,355 | — | |
| Jun 10, 2026 AMForm 4 → | Jun 12, 8:12 pm EDT | Donald Allen WilliamsDirector | 1,559,566 | — | — | 1,570,294 | — | |
| Jun 10, 2026 AMForm 4 → | Jun 12, 8:11 pm EDT | Emil ChuangDirector | 612,500 | — | — | 612,500 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 8:09 pm EDT | Jordan Michael ZwickDirector | 336,904 | — | — | 336,904 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2026 MForm 4 → | Jul 8, 6:52 pm EDT | Mitchell Lawrence JonesChief Medical Officer | 131,167 | — | — | 655,833 | — | |
| Jul 6, 2026 MForm 4 → | Jul 8, 6:49 pm EDT | John David FinleyCEO, CFO, Director | 335,300 | — | — | 0 | — | |
| Jun 10, 2026 MForm 4 → | Jun 12, 8:14 pm EDT | Binxian WeiDirector | 20,200 | — | — | 40,400 | — | |
| Jun 10, 2026 MForm 4 → | Jun 12, 8:12 pm EDT | Donald Allen WilliamsDirector | 60,666 | — | — | 121,334 | — | |
| Jun 10, 2026 MForm 4 → | Jun 12, 8:11 pm EDT | Emil ChuangDirector | 20,200 | — | — | 40,400 | — |